Growth Metrics

HNO International (HNOI) EBITDA (2022 - 2026)

HNO International's EBITDA history spans 5 years, with the latest figure at -$116852.0 for Q1 2026.

  • For the quarter ending Q1 2026, EBITDA rose 97.84% year-over-year to -$116852.0, compared with a TTM value of -$1.1 million through Jan 2026, up 86.7%, and an annual FY2025 reading of -$6.4 million, down 100.31% over the prior year.
  • EBITDA for Q1 2026 was -$116852.0 at HNO International, up from -$119625.0 in the prior quarter.
  • The five-year high for EBITDA was -$116852.0 in Q1 2026, with the low at -$5.4 million in Q1 2025.
  • Average EBITDA over 5 years is -$814478.7, with a median of -$431268.0 recorded in 2025.
  • Year-over-year, EBITDA plummeted 1040.16% in 2025 and then soared 97.84% in 2026.
  • Tracing HNOI's EBITDA over 5 years: stood at -$278426.0 in 2022, then plummeted by 240.07% to -$946840.0 in 2023, then plummeted by 81.68% to -$1.7 million in 2024, then surged by 93.05% to -$119625.0 in 2025, then rose by 2.32% to -$116852.0 in 2026.
  • Per Business Quant, the three most recent readings for HNOI's EBITDA are -$116852.0 (Q1 2026), -$119625.0 (Q4 2025), and -$431268.0 (Q3 2025).